Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on May 22, 2019, 10:42:10 am
-
Nearly all those in an ongoing Italian study of real-world use of Mavyret (glecaprevir/pibrentasvir) have been cured of hepatitis C virus (HCV).
Presenting their findings at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, researchers enrolled 1,178 people with hep C in the MISTRAL study, recruiting them at 22 clinics in Southern Italy. A total of 90.8 percent of the participants were prescribed eight weeks of Mavyret; 8.7 percent were prescribed 12 weeks; and 0.4 percent were prescribed 16 weeks of treatment.
Read more...
https://www.hepmag.com/article/mavyret-cures-hepatitis-c-high-rate-realworld-use